Drugs / QBM076
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02890069 | Oct 2016 → Feb 2022 | colorectal cancer, non-small cell lung carcinoma, renal cell carcinoma | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01972776 | Nov 2013 → May 2015 | chronic obstructive pulmonary disease | Novartis Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QBM076 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02890069 ↗ |